Alvotech ALVO
NASDAQ ALVO
$5.18 -0.01 (-0.10%)
As of: Sep 9, 2026 · 2:50 PM EDT

Alvotech (ALVO) Net Margin Growth (3y) (2025 - 2026)

Analysis

Alvotech (ALVO) Net Margin Growth (3y) (2025 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (3y) (Qtr)
1 Teva Pharmaceutical Industries 42.56 Bn 38.90 Bn 2.15 Bn 948.00
2 Viatris 19.17 Bn 18.28 Bn 1.46 Bn -990.00
3 Dr Reddys Laboratories 9.88 Bn 9.71 Bn 396.53 Mn -1,504.00
4 Amneal Pharmaceuticals 5.47 Bn 5.35 Bn 334.51 Mn 675.00
5 Bausch Health Companies 2.35 Bn 507.63 Mn 2.10 Bn 787.00
6 Alvotech 1.50 Bn 1.36 Bn 2.56 Mn -228,760.00
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn 427.00
8 Amphastar Pharmaceuticals 996.39 Mn 706.27 Mn 93.47 Mn -163.00
9 Fennec Pharmaceuticals 401.41 Mn 360.16 Mn 17.15 Mn 17,272.00
10 RedHill Biopharma 176.59 Mn 176.59 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -228,760.00
Dec 31, 2025 1.45 Mn
Jun 30, 2025 -118,375.00